Home > Drug Search >
  • company_query: Agennix
  •   > 
Drug Filter
Category:
chemistry (34) biology (6)
Status:
Approved (4) NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (21) Phase Ⅰ (8)
Clinical Stage:
Pending (2) Active (19) Discontinued (15)
Bio-Type:
Recombinant enzyme (3) Whole antibody (2)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Alzheimer's disease (AD) (2) Angina pectoris (1) Asthma (2) Benign prostatic hypertrophy (1) Chemotherapy-induced nausea and vomiting (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (2) Cognitive disorders (2) Crohn's disease (1) Diabetic nephropathy (1) Diarrhea (1) Dysmenorrhea (1) Friedreich's ataxia (1) Gastric cancer (1) HCV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (3) Tumour lysis syndrome (1) Hypertension (1) Irritable bowel syndrome (IBS) (1) Lymphoma (1) Malignant brain tumor (1) Metastatic melanoma (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Niemann-Pick diseases (1) Overactive bladder (OAB) (1) Postmenopausal osteoporosis (1) Psoriatic arthritis (1) Pulmonary arterial hypertension (1) Solid tumours (4) Type 2 diabetes (1) Urinary incontinence (1) Head and neck cancer (1) Oesophageal varices (1) Pain (1) Systemic inflammatory response syndrome (SIRS) (1) Diabetes (1) Acute myocardial infarction (AMI) (1) Post-traumatic stress disorder (1) Acromegaly (1) Alcoholism (2) Intermittent explosive disorder (1) Smallpox infection (1) Esophagus cancer (1) Neuroendocrine tumors (NET) (1) Plaque psoriasis (1) Gout (1) Cough (1) Ocular pain (1) Ocular inflammation (1)
Country:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top